Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci

Infection

Volumn 41, Issue 2, 2013, Pages 305-310

  Mutters, N T ^a   Frank, U ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Statistical bias; Systematic errors; Vancomycin resistant enterococci (VRE); VRE epidemiology

Indexed keywords

VANCOMYCIN;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPIDEMIOLOGY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BIAS (EPIDEMIOLOGY); DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GERMANY, WEST; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL BED CAPACITY, 500 AND OVER; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANCE;

EID: 84879498379     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0410-6     Document Type: Article

References (22)

1. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13(47):1-11. pii: 19046.
2. Murray BE. Diversity among multidrug-resistant enterococci. Emerg Infect Dis. 1998;4(1):37-47.
3. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY antimicrobial surveillance program (1997-2002). Diagn Microbiol Infect Dis. 2004;50(1):59-69. doi: 10.1016/j.diagmicrobio.2004.05.003.
4. Haas EJ, Zaoutis TE, Prasad P, Li M, Coffin SE. Risk factors and outcomes for vancomycin-resistant enterococcus bloodstream infection in children. Infect Control Hosp Epidemiol. 2010;. doi: 10.1086/655464.
5. Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, et al. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control. 2009;37(9):734-40. doi: 10.1016/j.ajic.2008.09.025.
6. Theilacker C, Jonas D, Huebner J, Bertz H, Kern WV. Outcomes of invasive infection due to vancomycin-resistant Enterococcus faecium during a recent outbreak. Infection. 2009;37(6):540-3. doi: 10.1007/s15010-009-9023-5.
7. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis. 2007;20(4):391-6. doi: 10.1097/QCO.0b013e32818be6f7.
8. Weinstein JW, Tallapragada S, Farrel P, Dembry LM. Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci. J Clin Microbiol. 1996;34(1):210-2.
9. Milstone AM, Maragakis LL, Carroll KC, Perl TM. Targeted surveillance to identify children colonized with vancomycin-resistant Enterococcus in the pediatric intensive care unit. Infect Control Hosp Epidemiol. 2010;31(1):95-8. doi: 10.1086/649221.
10. Yoonchang SW, Peck KR, Kim OS, Lee JH, Lee NY, Oh WS, et al. Efficacy of infection control strategies to reduce transmission of vancomycin-resistant enterococci in a tertiary care hospital in Korea: a 4-year follow-up study. Infect Control Hosp Epidemiol. 2007;28(4):493-5. doi: 10.1086/513024.
11. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995;33(5):1434.
12. Eigner U, Holfelder M, Oberdorfer K, Betz-Wild U, Bertsch D, Fahr AM. Performance of a matrix-assisted laser desorption ionization-time-of-flight mass spectrometry system for the identification of bacterial isolates in the clinical routine laboratory. Clin Lab. 2009;55(7-8):289-96.
13. Kobayashi I, Muraoka H, Iyoda T, Nishida M, Hasegawa M, Yamaguchi K. Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK 2 system, and comparison with two NCCLS reference methods. J Med Microbiol. 2004;53(Pt 12):1229-32. doi: 10.1099/jmm.0.45765-0.
14. Dombradi Z, Bihari Z, Horvath KI, Szabo J. Comparison of the VITEK 2 system with the E-test for the determination of glycopeptide susceptibility of vanA and vanC positive enterococci. Acta Microbiol Immunol Hung. 2010;57(3):157-63. doi: 10.1556/AMicr.57.2010.3.1.
15. van Den Braak N, Goessens W, van Belkum A, Verbrugh HA, Endtz HP. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. J Clin Microbiol. 2001;39(1):351-3. doi: 10.1128/JCM.39.1.351-353.2001.
16. Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A. Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis. 2000;19(11):816-22.
17. Goossens H, Jabes D, Rossi R, Lammens C, Privitera G, Courvalin P. European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates. J Antimicrob Chemother. 2003;51[Suppl 3]:iii5-12. doi: 10.1093/jac/dkg271.
18. Sagel U, Schulte B, Heeg P, Borgmann S. Vancomycin-resistant enterococci outbreak, Germany, and calculation of outbreak start. Emerg Infect Dis. 2008;14(2):317-9.
19. Hartman JM, Forsen JW Jr, Wallace MS, Neely JG. Tutorials in clinical research: part IV: recognizing and controlling bias. Laryngoscope. 2002;112(1):23-31. doi: 10.1097/00005537-200201000-00005.
20. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32(1-2):51-63.
21. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118(1):146-55.
22. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med. 2001;135(7):484-92.